LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

19.52 -1.11

Resumen

Variación precio

24h

Actual

Mínimo

19.41

Máximo

20

Métricas clave

By Trading Economics

Ingresos

67M

-681K

Ventas

-2.9M

17M

P/B

Media del Sector

48.528

77.671

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+4.59% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.35%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

49M

394M

Apertura anterior

20.63

Cierre anterior

19.52

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

195 / 374 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

11 dic 2025, 23:58 UTC

Adquisiciones, fusiones, absorciones

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

11 dic 2025, 23:56 UTC

Ganancias

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

11 dic 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

11 dic 2025, 22:06 UTC

Adquisiciones, fusiones, absorciones

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

11 dic 2025, 21:50 UTC

Ganancias

Costco Same-Store Sales, Membership Fees Rose in 1Q

11 dic 2025, 23:45 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

11 dic 2025, 23:44 UTC

Charlas de Mercado

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

11 dic 2025, 23:37 UTC

Charlas de Mercado

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

11 dic 2025, 23:31 UTC

Ganancias

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11 dic 2025, 22:48 UTC

Adquisiciones, fusiones, absorciones

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

11 dic 2025, 22:35 UTC

Ganancias

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

11 dic 2025, 22:30 UTC

Ganancias

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

11 dic 2025, 22:09 UTC

Adquisiciones, fusiones, absorciones

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

11 dic 2025, 22:06 UTC

Adquisiciones, fusiones, absorciones

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

11 dic 2025, 22:05 UTC

Ganancias

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11 dic 2025, 21:51 UTC

Adquisiciones, fusiones, absorciones

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

11 dic 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

11 dic 2025, 21:39 UTC

Ganancias

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

11 dic 2025, 21:39 UTC

Ganancias

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

11 dic 2025, 21:38 UTC

Ganancias

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

11 dic 2025, 21:37 UTC

Ganancias

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

11 dic 2025, 21:37 UTC

Charlas de Mercado

Broadcom Sees AI Revenue Doubling -- Market Talk

11 dic 2025, 21:34 UTC

Adquisiciones, fusiones, absorciones

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

11 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

Dexus Aiming for Long-Term Holding of A$50M in Fund

11 dic 2025, 21:28 UTC

Charlas de Mercado

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

11 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Dexus Expects to Introduce Additional Third-Party Equity in FY26

11 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Dexus: Third Party Investors to Contribute Remainder

11 dic 2025, 21:27 UTC

Adquisiciones, fusiones, absorciones

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

11 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

11 dic 2025, 21:25 UTC

Adquisiciones, fusiones, absorciones

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

4.59% repunte

Estimación a 12 Meses

Media 20.5 USD  4.59%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

3

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

195 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat